|
ADRBK2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.25870000000639E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.159850E-04 |
| Normal-vs-Stage2 |
1.784060E-04 |
| Normal-vs-Stage3 |
1.53408999999938E-05 |
| Normal-vs-Stage4 |
1.85129999996647E-06 |
| Stage1-vs-Stage2 |
2.778000E-01 |
| Stage1-vs-Stage3 |
1.738830E-01 |
| Stage1-vs-Stage4 |
3.957600E-02 |
| Stage2-vs-Stage3 |
9.371000E-01 |
| Stage2-vs-Stage4 |
4.353400E-01 |
| Stage3-vs-Stage4 |
3.298000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.69120000000001E-05 |
| Normal-vs-AfricanAmerican |
6.241900E-03 |
| Normal-vs-Asian |
3.51840000000214E-05 |
| Caucasian-vs-AfricanAmerican |
8.088600E-01 |
| Caucasian-vs-Asian |
2.036200E-01 |
| AfricanAmerican-vs-Asian |
4.946200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.81590000000776E-05 |
| Normal-vs-Female |
1.50330000003862E-06 |
| Male-vs-Female |
8.564000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.392600E-04 |
| Normal-vs-Age(41-60Yrs) |
8.81079999959233E-07 |
| Normal-vs-Age(61-80Yrs) |
2.19360000000002E-05 |
| Normal-vs-Age(81-100Yrs) |
3.006000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.295980E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.626380E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.566200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.624400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.783800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.921600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.324630E-01 |
| Classical-VS-Follicular |
3.303300E-03 |
| Classical-VS-Other |
2.823200E-01 |
| Classical-VS-Normal |
1.776720E-04 |
| Tall-VS-Follicular |
7.327000E-01 |
| Tall-VS-Other |
7.917600E-01 |
| Tall-VS-Normal |
5.037000E-04 |
| Follicular-VS-Other |
9.195600E-01 |
| Follicular-VS-Normal |
2.18419999975517E-07 |
| Other-VS-Normal |
1.981980E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.74020000035469E-07 |
| Normal-vs-N1 |
3.91579999980962E-07 |
| N0-vs-N1 |
1.487190E-01 |
|
|
